Holen Sie sich die Stockscreener-App
319.04
2.19%
-7.16
Vorhandelsmarkt:
319.04
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$326.20
Offen:
$322.84
24-Stunden-Volumen:
733.50K
Relative Volume:
0.66
Marktkapitalisierung:
$31.32B
Einnahmen:
$3.17B
Nettoeinkommen (Verlust:
$642.63M
KGV:
29.64
EPS:
10.765
Netto-Cashflow:
$516.49M
1W Leistung:
+0.44%
1M Leistung:
+10.01%
6M Leistung:
-4.73%
1J Leistung:
-0.64%
1-Tages-Spanne:
$317.41
$327.00
1-Wochen-Bereich:
$316.24
$333.68
52-Wochen-Spanne:
$275.05
$414.15
Waters Corp Stock (WAT) Company Profile
Firmenname
Waters Corp
Sektor
Branche
Telefon
(508) 478-2000
Adresse
34 MAPLE ST, MILFORD, MA
Compare WAT vs TMO, DHR, IDXX, A
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
WAT
Waters Corp
|
319.04 | 32.02B | 3.17B | 642.63M | 516.49M | 10.77 |
TMO
Thermo Fisher Scientific Inc
|
516.00 | 197.58B | 44.56B | 6.72B | 6.29B | 17.74 |
DHR
Danaher Corp
|
193.78 | 140.22B | 24.57B | 3.60B | 5.26B | 5.051 |
IDXX
Idexx Laboratories Inc
|
569.95 | 46.13B | 4.30B | 1.06B | 1.04B | 13.08 |
A
Agilent Technologies Inc
|
118.25 | 33.85B | 7.07B | 1.29B | 993.00M | 4.5355 |
Waters Corp Stock (WAT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-04-06 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2026-02-10 | Fortgesetzt | Barclays | Overweight |
| 2026-02-10 | Fortgesetzt | Citigroup | Buy |
| 2026-02-10 | Fortgesetzt | Evercore ISI | In-line |
| 2026-01-06 | Eingeleitet | Guggenheim | Buy |
| 2026-01-05 | Eingeleitet | William Blair | Outperform |
| 2025-12-10 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2025-12-02 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2025-10-08 | Eingeleitet | Rothschild & Co Redburn | Buy |
| 2025-03-31 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2025-03-26 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2025-02-13 | Hochstufung | Scotiabank | Sector Perform → Sector Outperform |
| 2025-02-10 | Hochstufung | Barclays | Underweight → Equal Weight |
| 2025-01-10 | Hochstufung | Bernstein | Mkt Perform → Outperform |
| 2024-12-23 | Eingeleitet | Scotiabank | Sector Perform |
| 2024-10-08 | Hochstufung | Jefferies | Hold → Buy |
| 2024-08-28 | Eingeleitet | Wells Fargo | Overweight |
| 2024-08-01 | Hochstufung | Leerink Partners | Market Perform → Outperform |
| 2024-06-03 | Fortgesetzt | Jefferies | Hold |
| 2023-11-13 | Herabstufung | Barclays | Equal Weight → Underweight |
| 2023-09-28 | Eingeleitet | Bernstein | Mkt Perform |
| 2023-07-31 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2023-07-31 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2022-12-14 | Eingeleitet | Deutsche Bank | Hold |
| 2022-08-25 | Eingeleitet | Credit Suisse | Neutral |
| 2022-07-20 | Eingeleitet | UBS | Neutral |
| 2022-05-18 | Eingeleitet | Barclays | Overweight |
| 2022-05-17 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2022-04-25 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2021-10-15 | Fortgesetzt | Cowen | Market Perform |
| 2021-07-06 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2021-01-07 | Herabstufung | Wells Fargo | Equal Weight → Underweight |
| 2020-12-17 | Hochstufung | Cleveland Research | Underperform → Buy |
| 2020-12-16 | Hochstufung | Citigroup | Sell → Neutral |
| 2020-12-02 | Eingeleitet | Goldman | Neutral |
| 2020-11-10 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2020-07-28 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2020-07-16 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2020-01-08 | Herabstufung | Needham | Hold → Underperform |
| 2020-01-08 | Eingeleitet | Wells Fargo | Underweight |
| 2020-01-07 | Eingeleitet | Citigroup | Sell |
| 2019-11-15 | Eingeleitet | Stifel | Hold |
| 2019-10-09 | Herabstufung | Barclays | Equal Weight → Underweight |
| 2019-07-16 | Herabstufung | BofA/Merrill | Neutral → Underperform |
| 2019-06-12 | Herabstufung | Cleveland Research | Neutral → Underperform |
| 2019-05-30 | Eingeleitet | Wolfe Research | Underperform |
| 2019-01-24 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2019-01-03 | Hochstufung | BofA/Merrill | Underperform → Neutral |
| 2019-01-03 | Eingeleitet | Needham | Hold |
| 2018-12-12 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2018-11-30 | Herabstufung | Goldman | Neutral → Sell |
| 2018-10-11 | Hochstufung | Cleveland Research | Sell → Neutral |
Alle ansehen
Waters Corp Aktie (WAT) Neueste Nachrichten
New Southern Waters company the biggest in South Island - The Central App
Waters Corporation $WAT Shares Sold by Sumitomo Mitsui Trust Group Inc. - MarketBeat
Short Interest in Waters Corporation (NYSE:WAT) Increases By 29.0% - MarketBeat
Waters Corp. stock underperforms Wednesday when compared to competitors - MarketWatch
WAT SEC FilingsWaters 10-K, 10-Q, 8-K Forms - Stock Titan
Waters Announces CE Mark for Next-Generation Fully Automated BD BACTEC FXI Culture System for Bloodstream Infection Diagnosis - Finviz
Waters Corporation's Q1 2026 Earnings: What to Expect - inkl
Waters Corp stock (US94106L1098): Why its leadership in analytical instruments matters more now for - AD HOC NEWS
Waters Corp. stock underperforms Tuesday when compared to competitors despite daily gains - MarketWatch
Waters prices $3.5B senior notes offering - MSN
Waters Debuts Industry-First Extended-Range MALS Detector for UHPLC/UPLC, Powering Rapid Characterization of Large Molecules - marketscreener.com
Waters Debuts Industry-First Extended-Range MALS Detector for UHPLC/UPLC, Powering Rapid Characterization of Large Molecules – Company AnnouncementFT.com - Financial Times
Cardinal Capital Management's Waters Corp(WAT) Holding History - GuruFocus
Waters Corp. stock underperforms Monday when compared to competitors despite daily gains - MarketWatch
Big Picture: Will Waters Corporation outperform small cap indexes2026 Trends & Technical Pattern Recognition Alerts - baoquankhu1.vn
Street Calls of the Week By Investing.com - Investing.com India
IAWAI growth assumptions questioned as waters company prepares strategy - Waikato Times
WAT Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
Massachusetts Financial Services Co. MA Sells 64,978 Shares of Waters Corporation $WAT - MarketBeat
Waters Corporation (NYSE: WAT) Reports First Quarter 2022 Financial Results - ADVFN
Waters Corporation (NYSE: WAT) Reports First Quarter 2021 Financial Results - ADVFN
Waters Corp Achieves Highest Daily Trading Volume of $270 Million, Rising 0.74% as Earnings Outlook Adjusts - Bitget
Waters Corporation (WAT) stock price, news, quote and history - Yahoo Finance Australia
WAT Earnings History & Surprises | EPS & Revenue Results | WATERS CORP (NYSE:WAT) - ChartMill
Waters (NYSE: WAT) highlights BD acquisition, 7% 2025 growth and performance-linked executive pay - Stock Titan
HARTFORD HEALTHCARE HLS FUND's Waters Corp(WAT) Holding History - GuruFocus
Rep. Gilbert Ray Cisneros, Jr. Buys Waters Corporation (NYSE:WAT) Stock - MarketBeat
WAT Stock Price, Quote & Chart | WATERS CORP (NYSE:WAT) - ChartMill
Waters (WAT) Gains FDA Clearance for At-Home Cervical Cancer Scr - GuruFocus
Waters Corp. stock outperforms competitors on strong trading day - MarketWatch
Waters Corp Stock Surges on FDA Clearance: What Investors Need to Know Now - AD HOC NEWS
Waters Stock Shoots Higher As FDA Clears At-Home Cervical Cancer Screening KitWaters (NYSE:WAT) - Benzinga
Waters Announces FDA Clearance of the Most Comprehensive At-Home Cervical Cancer Screening Tool, the Onclarity HPV Self-Collection Kit and FDA-Approved HPV Assay - Finviz
US FDA approves Waters' at‑home cervical cancer screening kit - Reuters
Waters (WAT) Gains FDA Approval for At-Home Cervical Cancer Scre - GuruFocus
FDA clears at-home HPV kit as 60% of cervical cancer cases hit unscreened people - Stock Titan
Waters Corp stock: What investors need to know in today's market - AD HOC NEWS
[Form 4] WATERS CORP /DE/ Insider Trading Activity - Stock Titan
Waters Corporation (NYSE:WAT) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
Evercore ISI upgrades Waters stock rating on achievable targets By Investing.com - Investing.com Australia
Evercore ISI upgrades Waters stock rating on achievable targets - Investing.com
Waters Corp : Evercore ISI Raises to Outperfo - Moomoo
Manufacturing Excellence Awards 2026: Waters Corp. - Worcester Business Journal
WAT Financials: Revenue Breakdown, Margins & Competitor Comparison - intellectia.ai
Waters Corporation (WAT) Stock Price, News, Quote & History - Yahoo! Finance Canada
Waters Corp (WAT) director gets deferred stock units grant - Stock Titan
Director Heather Knight granted deferred Waters (NYSE: WAT) stock units - Stock Titan
Waters Corp (MIL:1WAT) Bonds - GuruFocus
Parkman Healthcare Partners LLC's Waters Corp(WAT) Holding History - GuruFocus
Goldman Sachs Reinstates Buy Rating on Waters (WAT) Stock - GuruFocus
Waters Corp. stock rises Tuesday, still underperforms market - MarketWatch
Finanzdaten der Waters Corp-Aktie (WAT)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.27%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):